Copyright
        ©2007 Baishideng Publishing Group Co.
    
    
        World J Gastroenterol. Dec 28, 2007; 13(48): 6608-6611
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6608
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6608
            Table 1 Laboratory values
        
    | Date | AST | ALT | ALP | TB | DB | WBC | Neu | PT (%) | 
| 29/12/5 | 70 | 55 | 197 | 0.5 | 0.14 | 247 | 148.2 | |
| 21/2/6 | 9 | 13 | 330 | 0.3 | 0.08 | 5.78 | 4.769 | |
| 10/5/6 | 38 | 49 | 204 | 0.47 | 0.1 | |||
| 31/5/6 | 1060 | 1493 | 288 | 0.68 | 0.2 | |||
| 14/6/6 | 2224 | 3185 | 648 | 8.43 | 5.45 | |||
| 16/6/6 | 2595 | 3028 | 668 | 12.19 | 7.65 | 30 | ||
| 21/6/6 | 1887 | 1941 | 831 | 25.4 | 19.81 | 9.86 | 7.701 | 13 | 
| 22/6/6 | 1626 | 1757 | 756 | 26 | 20.28 | 9.47 | 7.59 | 11 | 
| 23/6/6 | 1495 | 1752 | 793 | 27 | 20.79 | 10 | 7.36 | 9 | 
| 24/6/6 | 1467 | 1767 | 800 | 26.8 | 21.44 | 14.4 | 11.16 | 9 | 
| 25/6/6 | 1359 | 1553 | 789 | 32 | 23.36 | 17 | 12.75 | 6 | 
| 26/6/6 | 1212 | 1121 | 774 | 36 | 26.64 | 22.2 | 17.1 | 6 | 
| 27/6/6 | 1024 | 900 | 686 | 24.7 | 9.5 | 86.8 | 39.9 | N-M1 | 
| 28/6/6 | 1269 | 561 | 362 | 11.5 | 4.8 | 42 | 33.6 | N-M1 | 
            Table 2 Summary of previously reported cases of serious (fatal and non-fatal) drug-induced liver damage following treatment with imatinib mesylate
        
    | Reference | Diagnosis | Time tohepaticdysfunction | Liverhistology | Outcome ofliver enzymes | 
| Ohyashiki et al (2002) | CML | 12 d | Focal necrosis of hepatocytes | Resolution after stopping drug | 
| Lin et al (2003) | Polycythemia vera | 7 wk | Hepatic necrosis | Patient died fatal acute hepatic necrosis | 
| James et al (2003) | CML | 49 wk | Acute severe cytolytic hepatitis. | Resolution after stopping drug | 
| With necrosis and mild cholestasis | ||||
| CML | 22 wk | Acute cytolytic hepatitis with spotty and some piecemeal necrosis | Resolution after stopping drug | |
| Kikuchi et al (2004) | CML | 36 wk | Hepatic necrosis | Resolution after stopping drug | 
| Ayoub et al (2005) | CML | 2 yr | Portal and lobular inflammation. | Resolution after stopping drug | 
| Bridging and multifocal lobular necrosis | ||||
| Cross et al (2007) | CML | 77 wk | Severe necrosis with multilobular confluent cell dropout and reticulin collapse, multinodular regeneration | Patient died 10 d after liver transplantation | 
| Ridruejo et al (2007) | CML | 22 wk | Not available | Patient died fatal acute hepatic necrosis | 
- Citation: Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mandó OG. Imatinib-induced fatal acute liver failure. World J Gastroenterol 2007; 13(48): 6608-6611
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6608.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6608

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        